Product logins

Find logins to all Clarivate products below.


Sports Medicine Devices | Market Insights | Europe | 2023

The European sports medicine market has recovered from the impact of the COVID-19 pandemic to some extent; however, the elective nature of the postponed surgeries is slowing recovery. Favorable demographics, investment in enabling technologies, uptake of premium-priced products, and increased availability and quality of surgeon training will help the market grow at a moderate pace through the forecast period. However, cost controls due to budgetary constraints, regulatory challenges, and the prevalence of alternative treatments will limit ASPs and revenue expansion over the forecast period.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for sports medicine devices in Europe from 2019 through 2031.

Related Medtech Insights Reports

Report
Urological Devices – Market Insights – Europe
The European urological device market is set to grow through 2034, driven by product innovation, rising awareness, increasing kidney stone cases, and an aging population. Growth will be led by BPH…
Report
Gynecological Devices – Market Insights – Europe
The European gynecological device market will see marginal growth over the forecast period, fueled by the ongoing adoption of office-based treatments, the increasing preference for minimally…
Report
Sports Medicine Devices – Market Insights – Japan
Technological investments, adoption of premium-priced products, increased market awareness through educational programs, improved surgeon training, and high levels of sports participation will…
Report
Interventional Oncology Devices – Market Insights – Europe
The European interventional oncology device market is projected to see modest growth through 2034, driven by rising cancer incidence and prevalence rates, updated clinical guidelines, and emerging…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be primarily driven by the high incidence of gastric cancer and CRC cases in the region. Growth will be supported by nationwide CRC and GI cancer…